Search research articles
Contact Us
Filters
Showing results (81-90 of 96) with videos related to
Page
of 10
Sort By:
Frontiers in Cardiovascular Medicine
|
July 21, 2022
Sex-Related Differences in Long-Term Outcomes After Early-Onset Myocardial Infarction
Maddalena Ardissino, Adam J Nelson, Giuseppe Maglietta, et al.
International Journal of Cardiology
|
September 20, 2018
Incidence and predictors of bleeding in ACS patients treated with PCI and prasugrel or ticagrelor: An analysis from the RENAMI registry
Fabrizio D'Ascenzo, Alberto Grosso, Emad Abu-Assi, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
May 21, 2019
Correction to: Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry
Ovidio De Fillippo, Martina Cortese, Fabrizio D Ascenzo, et al.
Revista Espanola De Cardiologia (English Ed.)
|
June 30, 2018
Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or Prasugrel
Sergio Raposeiras-Roubín, Emad Abu-Assi, Fabrizio D'Ascenzo, et al.
European Journal of Preventive Cardiology
|
March 14, 2019
Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry
Fabrizio D'Ascenzo, Maurizio Bertaina, Francesco Fioravanti, et al.
Revista Espanola De Cardiologia (English Ed.)
|
July 22, 2018
Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary Syndrome
Sergio Raposeiras-Roubín, Berenice Caneiro Queija, Fabrizio D'Ascenzo, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
April 29, 2019
Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry
Ovidio De Filippo, Martina Cortese, Fabrizio D Ascenzo, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
September 10, 2025
Impact of diabetes on outcomes of patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease undergoing percutaneous coronary intervention
Philipp Jakob, Ferdinando Varbella, Axel Linke, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
March 9, 2026
Impact of renal dysfunction on immediate versus staged revascularization of non-culprit lesions in patients with ST segment elevation myocardial infarction: a pre-specified subgroup analysis of the randomized MULTISTARS AMI trial
Miklos Rohla, Kurt Huber, Ferdinando Varbella, et al.
The New England Journal of Medicine
|
August 27, 2023
Timing of Complete Revascularization with Multivessel PCI for Myocardial Infarction
Barbara E Stähli, Ferdinando Varbella, Axel Linke, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 96) with videos related to
Sort By:
Page
of 10
Frontiers in Cardiovascular Medicine
|
July 21, 2022
Sex-Related Differences in Long-Term Outcomes After Early-Onset Myocardial Infarction
Maddalena Ardissino, Adam J Nelson, Giuseppe Maglietta, et al.
International Journal of Cardiology
|
September 20, 2018
Incidence and predictors of bleeding in ACS patients treated with PCI and prasugrel or ticagrelor: An analysis from the RENAMI registry
Fabrizio D'Ascenzo, Alberto Grosso, Emad Abu-Assi, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
May 21, 2019
Correction to: Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry
Ovidio De Fillippo, Martina Cortese, Fabrizio D Ascenzo, et al.
Revista Espanola De Cardiologia (English Ed.)
|
June 30, 2018
Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or Prasugrel
Sergio Raposeiras-Roubín, Emad Abu-Assi, Fabrizio D'Ascenzo, et al.
European Journal of Preventive Cardiology
|
March 14, 2019
Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry
Fabrizio D'Ascenzo, Maurizio Bertaina, Francesco Fioravanti, et al.
Revista Espanola De Cardiologia (English Ed.)
|
July 22, 2018
Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary Syndrome
Sergio Raposeiras-Roubín, Berenice Caneiro Queija, Fabrizio D'Ascenzo, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
April 29, 2019
Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry
Ovidio De Filippo, Martina Cortese, Fabrizio D Ascenzo, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
September 10, 2025
Impact of diabetes on outcomes of patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease undergoing percutaneous coronary intervention
Philipp Jakob, Ferdinando Varbella, Axel Linke, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
March 9, 2026
Impact of renal dysfunction on immediate versus staged revascularization of non-culprit lesions in patients with ST segment elevation myocardial infarction: a pre-specified subgroup analysis of the randomized MULTISTARS AMI trial
Miklos Rohla, Kurt Huber, Ferdinando Varbella, et al.
The New England Journal of Medicine
|
August 27, 2023
Timing of Complete Revascularization with Multivessel PCI for Myocardial Infarction
Barbara E Stähli, Ferdinando Varbella, Axel Linke, et al.
Page
of 10